Nanocurcumin supplementation ameliorates Behcet’s disease by modulating regulatory T cells: A randomized, double‐blind, placebo‐controlled trial
Samaneh Abbasian, Mohammad Sadegh Soltani‐Zangbar, Alireza Khabbazi, Rojin Farzaneh, Aida Malek Mahdavi, Roza Motavalli, Mehrzad Hajialilo, Mehdi Yousefi
Topics & Concepts
PlaceboFOXP3MedicineInternal medicineImmunologyGastroenterologyInterleukin 6Placebo-controlled studyCytokineEndocrinologyImmune systemPathologyDouble blindAlternative medicineOcular Diseases and Behçet’s SyndromeAutoimmune and Inflammatory Disorders ResearchInflammasome and immune disorders